Lexaria Bioscience LEXX
NASDAQ LEXX
$2.88 -0.21 (-6.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Price to Earnings (2024 - 2025)

Updated

Lexaria Bioscience's Price to Earnings came in at 78.84 for fiscal Q3 2025 (quarter ended May 31, 2025), up 650.3% from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Price to Earnings (2024 - 2025) Analysis & Trends

For FY2024 (ended Aug 31, 2024), Lexaria Bioscience's Price to Earnings was 4.46, up 330.2% from FY2023.

  • Going back by fiscal year, Price to Earnings was 1.04 in FY2023.
  • Business Quant data shows LEXX's Price to Earnings at 10.51 (Q2 2025), 7.69 (Q1 2025) and 10.66 (Q4 2024) in the three fiscal quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lexaria Bioscience 3.04 Mn -12.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2025 78.84
Feb 28, 2025 10.51
Nov 30, 2024 7.69
Aug 31, 2024 10.66
API Access

Lexaria Bioscience Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=LEXX&period=max&api_key=YOUR_API_KEY